The identification of accurate harbingers of disease status and therapeutic efficacy are
critical requirements in precise diagnosis and effective management. Initially, tissue analysis …

The management of neuroendocrine neoplasia remains a perplexing problem because of
the lack of knowledge of the biology of the disease, its late presentation, the relative …

Neuroendocrine tumors are a heterogeneous group of neoplasms originating from the
diffuse endocrine system. Depending on primary location and hormonal status, they range in …

Neuroendocrine neoplasms (NENs) are a heterogeneous group of diseases that are
characterized by different behavior and clinical manifestations. The diagnosis and …

Opinion statement Given the considerable heterogeneity in neuroendocrine neoplasms
(NENs), it appears unlikely that a sole biomarker exists capable of fully capturing all useful …

Tumor markers used in the diagnosis and follow-up of patients with neuroendocrine tumors
are in most instances not specific for a given tumor and circulate under normal conditions in …

Management of neuroendocrine neoplasia represents a clinical challenge because of its
late presentation, lack of treatment options, and limitations in present imaging modalities …

Neuroendocrine tumours (NETs) are neoplasms that arise from neuroendocrine cells.
Neuroendocrine cells and their tumours can secrete a wide range of amines and …

Simple Summary Neuroendocrine tumors are a collection of neoplastic lesions arising in
cells with traits similar to hormone-producing and nerve cells with the ability to secrete …

Background Multigene-based PCR tests are time-consuming and limiting aspects of the
protocol include increased risk of operator-based variation. In addition, such protocols are …